SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-020779
Filing Date
2020-02-14
Accepted
2020-02-14 08:10:31
Documents
14
Period of Report
2020-02-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm208083-1_8k.htm   iXBRL 8-K 34808
2 EXHIBIT 99.1 tm208083d1_ex99-1.htm EX-99.1 12946
6 GRAPHIC tm208083d1_ex99-1img001.jpg GRAPHIC 4398
  Complete submission text file 0001104659-20-020779.txt   235089

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA immu-20200213.xsd EX-101.SCH 3198
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20200213_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20200213_pre.xml EX-101.PRE 22718
11 EXTRACTED XBRL INSTANCE DOCUMENT tm208083-1_8k_htm.xml XML 3484
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

IRS No.: 611009366 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12104 | Film No.: 20614049
SIC: 2835 In Vitro & In Vivo Diagnostic Substances